ESG Report 2021

The Group is committed to producing high-quality institutions, it will be able to develop more products products for the people of the country, and is with higher quality and enhance the competitiveness constantly trying to seek innovation and of the Group. breakthrough in product research and development The Group also actively carried out innovative model. For the first time, the Group cooperated with research and development in different fields. Other the University of Macau in industry-university- scientific research achievements this year include: research cooperation. Leveraging on its extensive the technological development and industrialization experience in the basic research and application of project of memantine hydrochloride, a drug for the nano-preparations, the Group created better treatment of neurodegenerative diseases, was conditions for product research and development. awarded the first prize of Zhuhai Science and The joint research and development project of Technology Progress Award for 2020; the new “Research on the technology of New Mucus- product, Tazobactam, has passed the relevant penetrating Nanocrystal Eye Drops” for the verification of process and equipment and has treatment of Xerophthalmia has passed the strict entered the mass production stage; amoxicillin heavy review of the relevant technology, financial experts powder obtained domestic sales permit; among and government administrative departments, and them, five new process technology innovations obtained the financial assistance for the industry- brought direct economic benefits of RMB420 million university-research cooperation and basic and to the Group; the Group also carried out a number applied basic research project in Zhuhai City. The of innovative works such as environmental protection Group believes that through innovative product and intelligent transformation. research and development models and cooperation with different academic institutions and professional External Cooperation and Other Scientific Research Achievements FACILITATING THE DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY The Group is committed to promoting the Conference of Neurology and Annual Congress of development of the pharmaceutical industry, and Chinese Thoracic Society, covering a wide range of facilitates the promotion of pharmaceutical medical fields to promote academic exchanges and academic knowledge and information. During the pharmaceutical research. In addition, the Group Year, the Group actively participated in various in a actively participates in nationwide pharmaceutical number of online and offline pharmaceutical forums such as the China County Health academic conferences, such as the Annual Meeting Conference, China Pharmacists Week and Xiangya of Chinese Society of Endocrinology, Scientific Forum to promote the Group's new products and Meeting of the Chinese Diabetes Society, National keep abreast of the latest development in medicine. 20 Environmental, Social and Governance Report 2021 The United Laboratories International Holdings Limited